Posted on 27 April 2022
This work informs National Institute for Health and Care Excellence (NICE) decisions about which new drugs and technologies are approved for use in the NHS. There will also be opportunities to contribute to economic evaluations and quantitative syntheses across CRD research programmes. This may include decision analytic modelling and statistical analysis including parametric survival modelling, network meta-analysis and analysis of individual participant data.
This is a full-time position, but we will also consider applicants who wish to work part-time.
Apply by: 22nd May 2022
Interview date: 9th June 2022
For informal enquiries: please contact Dr Robert Hodgson (rob.hodgson@york.ac.uk) or Professor Sofia Dias (sofia.dias@york.ac.uk)